140 related articles for article (PubMed ID: 31435428)
1. Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme.
Chatzikonstantinou G; Ulrich P; Archavlis E; Zamboglou N; Strouthos I; Zoga E; Baltas D; Tselis N
J Contemp Brachytherapy; 2019 Jun; 11(3):215-220. PubMed ID: 31435428
[TBL] [Abstract][Full Text] [Related]
2. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
[TBL] [Abstract][Full Text] [Related]
3. Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a single institution study.
Tselis N; Chatzikonstantinou G; Kolotas C; Milickovic N; Baltas D; Zamboglou N
Eur Radiol; 2013 Aug; 23(8):2264-70. PubMed ID: 23515917
[TBL] [Abstract][Full Text] [Related]
4. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies.
Tselis N; Ferentinos K; Kolotas C; Schirren J; Baltas D; Antonakakis A; Ackermann H; Zamboglou N
J Thorac Oncol; 2011 Mar; 6(3):545-52. PubMed ID: 21258257
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma.
Ozyar E; Yildz F; Akyol FH; Atahan IL
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):101-8. PubMed ID: 11777627
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme.
Archavlis E; Tselis N; Birn G; Ulrich P; Baltas D; Zamboglou N
BMJ Open; 2013 Mar; 3(3):. PubMed ID: 23503605
[TBL] [Abstract][Full Text] [Related]
8. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated accelerated computed tomography-guided interstitial high-dose-rate brachytherapy for liver malignancies.
Tselis N; Chatzikonstantinou G; Kolotas C; Milickovic N; Baltas D; Chung TL; Zamboglou N
Brachytherapy; 2012; 11(6):507-14. PubMed ID: 22571828
[TBL] [Abstract][Full Text] [Related]
10. Factors determining acute normal tissue reactions during postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases.
Jereczek-Fossa BA; Badzio A; Jassem J
Radiother Oncol; 2003 Jul; 68(1):33-9. PubMed ID: 12885450
[TBL] [Abstract][Full Text] [Related]
11. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.
Wong WW; Vora SA; Schild SE; Ezzell GA; Andrews PE; Ferrigni RG; Swanson SK
Cancer; 2009 Dec; 115(23):5596-606. PubMed ID: 19670452
[TBL] [Abstract][Full Text] [Related]
12. High-dose-rate interstitial brachytherapy in head and neck cancer: do we need a look back into a forgotten art - a single institute experience.
Bhalavat R; Chandra M; Pareek V; Nellore L; George K; Nandakumar P; Bauskar P
J Contemp Brachytherapy; 2017 Apr; 9(2):124-131. PubMed ID: 28533800
[TBL] [Abstract][Full Text] [Related]
13. The effect of combined external beam radiotherapy and brachytherapy on local control and wound complications in patients with high-grade soft tissue sarcomas of the extremity with positive microscopic margin.
Alekhteyar KM; Leung DH; Brennan MF; Harrison LB
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):321-4. PubMed ID: 8892454
[TBL] [Abstract][Full Text] [Related]
14. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.
Martinez AA; Kestin LL; Stromberg JS; Gonzalez JA; Wallace M; Gustafson GS; Edmundson GK; Spencer W; Vicini FA
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):343-52. PubMed ID: 10802358
[TBL] [Abstract][Full Text] [Related]
15. Combined high dose rate brachytherapy and external beam radiotherapy for clinically localised prostate cancer.
Strouthos I; Chatzikonstantinou G; Zamboglou N; Milickovic N; Papaioannou S; Bon D; Zamboglou C; Rödel C; Baltas D; Tselis N
Radiother Oncol; 2018 Aug; 128(2):301-307. PubMed ID: 29764692
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of chemoradiation plus pulsed-dose-rate brachytherapy boost in anal canal carcinoma: A mono-institutional retrospective analysis.
Arcelli A; Buwenge M; Macchia G; Cammelli S; Deodato F; Cilla S; Galuppi A; Panni V; Mattiucci GC; Tagliaferri L; Morganti AG
J Contemp Brachytherapy; 2019 Feb; 11(1):21-27. PubMed ID: 30911306
[TBL] [Abstract][Full Text] [Related]
17. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.
Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Matsuura K; Ito K
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):767-75. PubMed ID: 10386633
[TBL] [Abstract][Full Text] [Related]
18. High-dose-rate interstitial brachytherapy in recurrent head and neck cancer: an effective salvage option.
Bhalavat R; Pareek V; Chandra M; Nellore L; George K; Borade D; Kalariya K; Moosa Z; Srivastava A; Reddy N; Kapoor A; Kawale D; P N; Bauskar P
J Contemp Brachytherapy; 2018 Oct; 10(5):425-430. PubMed ID: 30479619
[TBL] [Abstract][Full Text] [Related]
19. High-dose-rate stereotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes.
Chang CN; Chen WC; Wei KC; Ng SH; Ho YS; Huang DY; Lee SP; Hong JH
J Neurooncol; 2003 Jan; 61(1):45-55. PubMed ID: 12587795
[TBL] [Abstract][Full Text] [Related]
20. Interstitial brachytherapy for childhood soft tissue sarcoma.
Laskar S; Bahl G; Ann Muckaden M; Puri A; Agarwal MG; Patil N; Shrivastava SK; Dinshaw KA
Pediatr Blood Cancer; 2007 Oct; 49(5):649-55. PubMed ID: 17226842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
